The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease
Open accessAbstract
Evidence from postmortem studies suggest an involvement of oxidative stress in the degeneration of dopaminergic neurons in Parkinson disease (PD) that have recently been shown to die by apoptosis, but the relationship between oxidative stress and apoptosis has not yet been elucidated. Activation of the transcription factor NF-κB is associated with oxidative stress-induced apoptosis in several nonneuronal in vitro models. To investigate whether it may play a role in PD, we looked for the translocation of NF-κB from the cytoplasm to the nucleus, evidence of its activation, in melanized neurons in the mesencephalon of postmortem human brain from five patients with idiopathic PD and seven matched control subjects. In PD patients, the proportion of dopaminergic neurons with immunoreactive NF-κB in their nuclei was more than 70-fold that in control subjects. A possible relationship between the nuclear localization of NF-κB in mesencephalic neurons of PD patients and oxidative stress in such neurons has been shown in vitro with primary cultures of rat mesencephalon, where translocation of NF-κB is preceded by a transient production of free radicals during apoptosis induced by activation of the sphingomyelin-dependent signaling pathway with C 2 -ceramide. The data suggest that this oxidant-mediated apoptogenic transduction pathway may play a role in the mechanism of neuronal death in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Self-citationMelanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Self-citationNF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Self-citationSian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Self-citationSchulze-Osthoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A., & Fiers, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42768-8 · Cited by 939
The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
KOLESNICK, R. (1994) · Cell · doi:10.1016/0092-8674(94)90147-3 · Cited by 920
Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation
Grilli, M., Pizzi, M., Memo, M., & Spano, P. (1996) · Science · doi:10.1126/science.274.5291.1383 · Cited by 750
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Self-citationCeramide: an intracellular signal for apoptosis
Hannun, Y. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88961-6 · Cited by 595
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Self-citationSchulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., & Fiers, W. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05978.x · Cited by 577
Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537
Self-citationA 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
Baeuerle, P. A., & Baltimore, D. (1989) · Genes & Development · doi:10.1101/gad.3.11.1689 · Cited by 505
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454
Histochemical detection of apoptosis in Parkinson's disease
Mochizuki, H., Goto, K., Mori, H., & Mizuno, Y. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00336-z · Cited by 452
Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis.
Grimm, S., Bauer, M. K., Baeuerle, P. A., & Schulze-Osthoff, K. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.1.13 · Cited by 354
Heterogeneity of microtubule-associated protein 2 during rat brain development.
Binder, L. I., Frankfurter, A., Kim, H., Caceres, A., Payne, M. R., & Rebhun, L. I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5613 · Cited by 234
Terai, K., Matsuo, A., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00310-1 · Cited by 214
Ceramide Induces Apoptosis in Cultured Mesencephalic Neurons
Brugg, B., Michel, P. P., Agid, Y., & Ruberg, M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020733.x · Cited by 189
Self-citationFrance‐Lanord, V., Brugg, B., Michel, P. P., Agid, Y., & Ruberg, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041612.x · Cited by 182
Self-citationSchwarz, M. A., Lazo, J. S., Yalowich, J. C., Reynolds, I., Kagan, V. E., Tyurin, V., Kim, Y. M., Watkins, S. C., & Pitt, B. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36597-3 · Cited by 164
Kolesnick, R. N., Haimovitz‐Friedman, A., & FUKS, Z. Y. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-063 · Cited by 155
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. B. (1992) · Springer eBooks · doi:10.1007/978-3-642-77609-0_2 · Cited by 130
Synaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's Disease
Anglade, P., Prigent, A., Agid, Y., & Hirsch, É. C. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0018 · Cited by 117
Self-citationDoes Oxidative Stress Participate in Nerve Cell Death in Parkinson’s Disease?
Hirsch, É. C., & Hirsch, É. C. (2008) · European Neurology · doi:10.1159/000118538 · Cited by 106
Apoptosis II The molecular basis of apoptosis in disease
Griffin, M. (1995) · Biochemical Education · doi:10.1016/0307-4412(95)90210-4 · Cited by 99
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
Riederer, P. F., Dirr, A., Goetz, M. E., Sofic, E., Jellinger, K. A., & Youdimt, M. B. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320717 · Cited by 94
Michel, P. P., & Agid, Y. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041633.x · Cited by 87
Self-citationInduction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity
P�rez-Ota�o, I., McMillian, M., Chen, J. L., Bing, G., Hong, J. S., & Pennypacker, K. R. (1996) · Glia · Cited by 70
Distribution of manganese-dependent superoxide dismutase in the human brain
Zhang, P., Anglade, P., Hirsch, É. C., Javoy-Agid, F., & Agid, Y. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90234-8 · Cited by 60
Self-citation
Cited by
The Free Radical Theory of Aging Matures
BECKMAN, K. B., & AMES, B. N. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.2.547 · Cited by 3,879
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Liddelow, S. A., & Barres, B. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.006 · Cited by 2,336
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Metadata
- Authors
- Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-07-08
- Volume
- 94
- Issue
- 14
- Pages
- 7531-7536
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2086997247
- Cited by
- 678
- References
- 37
- FWCI
- 24.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.